Similar Articles

  • TOC Icon

    Radon and lung cancer: Assessing and mitigating the risk

    Humberto Choi, MD and Peter Mazzone, MD, MPH, FCCP
    • Cleveland Clinic Journal of Medicine September 2014, 81 (9) 567-575;
    • DOI: https://doi.org/10.3949/ccjm.81a.14046

    • Radon exposure is the second most common cause of lung cancer, but the evidence so far does not support screening for lung cancer in people exposed to it.

  • Chemotherapy in the management of breast cancer

    Maurie Markman, MD and Beth A. Overmoyer, MD
    • Cleveland Clinic Journal of Medicine January 1995, 62 (1) 36-50;
  • TOC Icon

    A minimally invasive treatment for early GI cancers

    Lady Katherine Mejía-Pérez, MD, Seiichiro Abe, MD, Tyler Stevens, MD, Mansour A. Parsi, MD, Sunguk N. Jang, MD, Ichiro Oda, MD, John J. Vargo, MD, MPH, Yutaka Saito, MD, PhD and Amit Bhatt, MD
    • Cleveland Clinic Journal of Medicine September 2017, 84 (9) 707-717;
    • DOI: https://doi.org/10.3949/ccjm.84a.16063

    • Endoscopic submucosal dissection allows curative resection of early malignant gastrointestinal lesions.

  • TOC Icon

    Air travel and venous thromboembolism: Minimizing the risk

    John R. Bartholomew, MD, Jonathan L. Schaffer, MD, MBA and Georges F. McCormick, MD
    • Cleveland Clinic Journal of Medicine February 2011, 78 (2) 111-120;
    • DOI: https://doi.org/10.3949/ccjm.78a.10138

    • Blood clots can occur during air travel, although the absolute risk is low. People with hypercoagulable conditions are at greater risk and may need prophylaxis.

  • Minimizing the risk of NSAID-induced GI bleeding

    William S. Wilke, MD and Basil I. Hirschowitz, MD
    • Cleveland Clinic Journal of Medicine October 1999, 66 (9) 524-527;

    • As many people die of NSAID-induced bleeding as die of AIDS. Physicians should prescribe these drugs more selectively, and advise patients to limit their use of over-the-counter products.

  • Assessing benefit-risk ratios

    Edward A. Mortimer Jr., M.D
    • Cleveland Clinic Journal of Medicine December 1982, 49 (4) 235-238;

  • DXA and fracture risk assessment

    • Cleveland Clinic Journal of Medicine December 2021, 88 (12) 659;

    • The following article contained an error: Williams S, Khan L, Licata AA. DXA and clinical challenges of fracture risk assessment in primary care. Cleve Clin J Med 2021; 88(11):615–622. doi:10.3949/ccjm.88a.20199

  • Genetic discrimination arising from cancer risk assessments: A societal dilemma

    Maurie Markman, MD
    • Cleveland Clinic Journal of Medicine January 2004, 71 (1) 12;

    • The right to privacy of one’s most intimate biological secrets must be affirmed.

  • Reproductive health and the environment: Counseling patients about risks

    Bella Haruty, MPH, REHS, Julie Friedman, MPH, CHES, Stephanie Hopp, MHS, MS, Ryane Daniels, MPHC and Janet Pregler, MD
    • Cleveland Clinic Journal of Medicine May 2016, 83 (5) 367-372;
    • DOI: https://doi.org/10.3949/ccjm.83a.14070

    • Endocrine-disrupting chemicals are ubiquitous and affect multiple pathways. The precautionary principle should apply.

  • Reducing the risk of breast cancer

    Holly J. Pederson, MD, Zahraa Al-Hilli, MD and Allison W. Kurian, MD
    • Cleveland Clinic Journal of Medicine November 2022, 89 (11) 643-652;
    • DOI: https://doi.org/10.3949/ccjm.89a.21113

    • Breast cancer remains the most common malignancy in US women. Reducing this burden involves identification of high-risk individuals and personalized risk management.

Previous
Next